scholarly article | Q13442814 |
P50 | author | Beatrice M. Filippi | Q42175280 |
P2093 | author name string | Maureen J Charron | |
Jessica T Y Yue | |||
Carol K L Lam | |||
Madhu Chari | |||
Tony K T Lam | |||
Clair S Yang | |||
Mona A Abraham | |||
Patricia I Mighiu | |||
Nikita R Christian | |||
P2860 | cites work | The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization | Q24309433 |
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Obesity wars: molecular progress confronts an expanding epidemic | Q28240764 | ||
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice | Q28510615 | ||
Central nervous system control of food intake and body weight | Q29619020 | ||
The mechanism underlying the central glucagon-induced hyperglycemia and anorexia in chicks | Q84837474 | ||
Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo | Q33637026 | ||
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover | Q34244209 | ||
Hypothalamic K(ATP) channels control hepatic glucose production | Q34413202 | ||
Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production | Q34768998 | ||
Hypothalamic AMP-activated protein kinase regulates glucose production | Q35757198 | ||
Hypothalamic resistin induces hepatic insulin resistance | Q35794048 | ||
Identification of glucagon receptors in rat brain | Q36272209 | ||
The hormonal control of food intake | Q36387304 | ||
Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity | Q36981204 | ||
Effect of glucagon on glucose production during insulin deficiency in the dog | Q37031782 | ||
Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia | Q37034985 | ||
Transient Stimulatory Effect of Sustained Hyperglucagonemia on Splanchnic Glucose Production in Normal and Diabetic Man | Q40049053 | ||
Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man | Q40529226 | ||
Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. | Q40529785 | ||
PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. | Q40931903 | ||
Regulation of gonadotropin-releasing hormone by protein kinase-A and -C in immortalized hypothalamic neurons | Q41548611 | ||
Pancreatic glucagon and postprandial satiety in the rat. | Q41621478 | ||
Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability | Q41863564 | ||
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice | Q41982493 | ||
Diet fat influences liver plasma-membrane lipid composition and glucagon-stimulated adenylate cyclase activity | Q42106430 | ||
Glucose transporter-1 in the hypothalamic glial cells mediates glucose sensing to regulate glucose production in vivo | Q42770564 | ||
Neuronal regulation of homeostasis by nutrient sensing | Q43106535 | ||
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents | Q43756107 | ||
Glycemic control in mice with targeted disruption of the glucagon receptor gene | Q43850844 | ||
Central action of glucagon in rat hypothalamus | Q44649516 | ||
Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin | Q45077923 | ||
Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. | Q46168291 | ||
Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats | Q46683459 | ||
Activation of central lactate metabolism lowers glucose production in uncontrolled diabetes and diet-induced insulin resistance | Q46815595 | ||
Central resistin induces hepatic insulin resistance via neuropeptide Y. | Q46886456 | ||
Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production | Q48145978 | ||
Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats | Q48349309 | ||
Lipid sensing and insulin resistance in the brain | Q48531280 | ||
Effect of intracerebroventricularly infused glucagon on feeding behavior | Q48625125 | ||
An automated method to quantify and visualize colocalized fluorescent signals. | Q51444072 | ||
Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. | Q52630455 | ||
Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects | Q67433381 | ||
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus | Q68917267 | ||
Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist | Q69364361 | ||
Decreased feeding and supraphysiological plasma levels of glucagon after glucagon injection in rats | Q69456176 | ||
Insulin and Glucagon Regulate Cytosolic Phosphoenolpyruvate Carboxykinase (GTP) mRNA in Rat Liver | Q70196881 | ||
Transient hepatic response to glucagon in man: role of insulin and hyperglycemia | Q70223364 | ||
Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats | Q72534738 | ||
Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist | Q72924516 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glucagon | Q28163629 |
P304 | page(s) | 766-772 | |
P577 | publication date | 2013-05-19 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Hypothalamic glucagon signaling inhibits hepatic glucose production. | |
P478 | volume | 19 |
Q42175219 | A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins |
Q64107107 | A hindbrain inhibitory microcircuit mediates vagally-coordinated glucose regulation |
Q45019496 | A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice |
Q53114917 | Accurate analytical method for human plasma glucagon levels using liquid chromatography-high resolution mass spectrometry: comparison with commercially available immunoassays. |
Q27025870 | Action and therapeutic potential of oxyntomodulin |
Q38318620 | Autonomic regulation of hepatic glucose production. |
Q37403334 | Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors |
Q36618049 | C. elegans Body Cavity Neurons Are Homeostatic Sensors that Integrate Fluctuations in Oxygen Availability and Internal Nutrient Reserves |
Q39146023 | Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides |
Q38164006 | Changing paradigms in type 2 diabetes mellitus |
Q48089600 | Evaluation of the specific effects of intranasal glucagon on glucose production and lipid concentration in healthy men during a pancreatic clamp |
Q41826321 | FGF19: How gut talks to brain to keep your sugar down |
Q34514766 | Fine mapping and candidate gene search of quantitative trait loci for growth and obesity using mouse intersubspecific subcongenic intercrosses and exome sequencing. |
Q37690695 | From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation |
Q90609508 | GABAA receptor currents in the dorsal motor nucleus of the vagus in females: influence of ovarian cycle and 5α-reductase inhibition |
Q38438335 | Glucagon action in the brain |
Q38203446 | Glucagon and lipid signaling in the hypothalamus |
Q38821167 | Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use. |
Q38622662 | Glucagon signalling in the dorsal vagal complex is sufficient and necessary for high-protein feeding to regulate glucose homeostasis in vivo |
Q41991612 | Glucagon's yin and yang effects on hepatic glucose production |
Q41764883 | Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance. |
Q57796329 | Hypothalamic Macrophage Inducible Nitric Oxide Synthase Mediates Obesity-Associated Hypothalamic Inflammation |
Q36077089 | Hypothalamic PKA regulates leptin sensitivity and adiposity |
Q90450802 | Hypothalamic dopamine signaling regulates brown fat thermogenesis |
Q38270388 | Hypothalamic glucagon signals through the KATP channels to regulate glucose production |
Q38380733 | Hypothalamic neurones governing glucose homeostasis |
Q37434371 | Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity |
Q64264350 | Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes? |
Q38409880 | Islet α cells and glucagon--critical regulators of energy homeostasis |
Q47837656 | Leptin enhances hypothalamic LDHA-dependent glucose sensing to lower glucose production in high-fat fed rats. |
Q42377847 | Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes |
Q30842243 | Neuroendocrine signaling modulates specific neural networks relevant to migraine |
Q33640082 | Neuronal control of peripheral insulin sensitivity and glucose metabolism |
Q28359714 | Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes |
Q38203645 | Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes. |
Q34206321 | Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response |
Q51337626 | Proteomic analysis of plasma from rats following total parenteral nutrition-induced liver injury. |
Q35156144 | Retracted: Hepatic Branch Vagus Nerve Plays a Critical Role in the Recovery of Post-Ischemic Glucose Intolerance and Mediates a Neuroprotective Effect by Hypothalamic Orexin-A |
Q92826783 | Role of Peptide Hormones in the Adaptation to Altered Dietary Protein Intake |
Q89230553 | Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates |
Q26748559 | Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy |
Q48635081 | Targeting the brain as a cure for type 2 diabetes |
Q38919742 | The New Biology and Pharmacology of Glucagon. |
Q90620848 | The kinetics of glucagon action on the liver during insulin-induced hypoglycemia |
Q88797110 | The vagus neurometabolic interface and clinical disease |
Q34550127 | Whole-body and hepatic insulin resistance in obese children |
Q34062820 | β(2)-Adrenoreceptor blockade improves early posttrauma hyperglycemia and pulmonary injury in obese rats |